We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Neurons that appear to be degenerating.
Product News

Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels To Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024

New comprehensive biomarker panels equip physicians with clinically actionable insights for earlier, more accurate diagnosis.
Someone putting a sample into a PCR rack.
Product News

Bio-Rad Outlines Its Advances Leveraging Droplet Digital PCR in Biopharma and Translational Research Sectors

Strategic collaborations in molecular residual disease monitoring of cancer and product launches in ddPCR portfolio advance corporate strategy in H1 2024.
Graph showing dispensing errors before (red) and after (green) introduction of degasser.
Product News

Inline Degasser Reduces Anomalies in Reagent Dispensing

Biotech Fluidics report how the installation of two DEGASi® Plus semi-prep 6-channel degassing systems on a production line has enabled a diagnostic kit manufacturer to almost eliminate inaccurate reagent dispensing issues.
A scientist pipetting into a tube.
Product News

Primerdesign Launches Real-Time PCR Workflow for Onsite Detection of Norovirus in Oysters

genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue.
Three researchers in a lab.
Product News

Thermo Fisher Scientific Launches Novel Personal Dosimetry Device To Monitor Radiation Exposure in Real-Time

Thermo Fisher Scientific has announced the launch of the Thermo Scientific™ NetDose™ Pro digital dosimeter, a wearable, connected device for monitoring radiation.
Cancer cells.
Product News

Association for Molecular Pathology Publishes Evidence-Based Recommendations for Tumor Mutational Burden Testing

AMP published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint inhibitor (ICI) therapies.
Advertisement